Estrogen-induced growth stimulation has not previously been demonstrated in
estrogen receptor (ER) cDNA transfected human cell lines in contrast to br
east cancer cell lines expressing endogenous ER. On the contrary, estrogen
usually inhibits cell growth of ER transfected cell lines. Growth inhibitio
n by estrogen has also been demonstrated in our cell line, F9, which is an
ER transfected subline of HMT-3522 breast epithelial cells derived from fib
rocystic disease and propagated in chemically defined medium. By omitting E
GF in the medium, we have demonstrated not only an increased transcriptiona
l activity of the ER but also-after an adaptation period-estrogen-dependent
growth of the cells, and we have succeeded in establishing a new subline,
S3B, that requires 17 beta-estradiol (E-2) for growth. This is the first ex
ample of a nonmalignant, human breast epithelial cell line which is depende
nt on estrogen for continued growth. The S3B cells express functional ER as
measured by transcriptional activity. ER-E-2 induced transcription was not
inhibited by EGF as in F9 cells. We propose that a growth-stimulatory resp
onse of breast epithelial cells in vitro to E-2 is dependent on an inactive
or down-regulated EGF receptor signaling pathway and it is possible that t
he effect of estrogen on normal breast epithelium in vivo also is modulated
by the EGFR. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.